NCT00144066
- Conditions
- Lung Cancer, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
Not specified
Clinical trial condition
Lung Neoplasms
Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.
3,668 public trials
792 recruiting studies
Lung Neoplasms trial results
NCT00073385
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
- Locations
-
- Wilshire Oncology Medical Group La Verne, California, United States
- Hematology and Oncology Specialists, LLC New Orleans, Louisiana, United States
- HemOnCare Brooklyn, New York, United States
- Montefiore Medical Center, Department of Oncology The Bronx, New York, United States
NCT00041808
- Conditions
- Adenocarcinoma, Breast Diseases, Breast Neoplasms, +49 more
- Locations
-
- Scripps Stevens Cancer Division San Diego, California, United States
- UCSF Cancer Center San Francisco, California, United States
- Scott and White Clinic Temple, Texas, United States
- Frankfurt Universtiy Frankfurt, Germany
Active, Not Recruiting
Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
NCT04491942
- Conditions
- Adenoma, Adnexal Diseases, Advanced Bile Duct Carcinoma, +72 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- National Cancer Institute Developmental Therapeutics Clinic Bethesda, Maryland, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center New York, United States
Active, Not Recruiting
MUC1 Vaccine in Preventing Lung Cancer in Current and Former Smokers at High Risk for Lung Cancer
NCT03300817
- Conditions
- Lung Carcinoma, Lung Diseases, Lung Neoplasms, +5 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
Active, Not Recruiting
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)
NCT03811002
- Conditions
- Limited Stage Lung Small Cell Carcinoma, Lung Diseases, Lung Neoplasms, +8 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Banner MD Anderson Cancer Center Gilbert, Arizona, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
Active, Not Recruiting
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction
NCT01366144
- Conditions
- Adnexal Diseases, Breast Carcinoma, Breast Diseases, +70 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- City of Hope South Pasadena South Pasadena, California, United States
- Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase Inhibitor
NCT02496663
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Stanford Cancer Institute Palo Alto Palo Alto, California, United States
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- UCHealth University of Colorado Hospital Aurora, Colorado, United States
Active, Not Recruiting
Testing the Timing of Pembrolizumab Alone or With Chemotherapy as First Line Treatment and Maintenance in Non-small Cell Lung Cancer
NCT03793179
- Conditions
- Lung Diseases, Lung Neoplasms, Lung Non-Squamous Non-Small Cell Carcinoma, +8 more
- Locations
-
- University of South Alabama Mitchell Cancer Institute Mobile, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
NCT02194738
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +14 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Southern Cancer Center PC-Daphne Daphne, Alabama, United States
- Southern Cancer Center PC-Mobile Mobile, Alabama, United States
- Southern Cancer Center PC-Providence Mobile, Alabama, United States